United States · Series D startup

Who invested in Kriya Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$321Mraised across 1 round since 2025, from 1 source

Latest round
Series D, $321MAug 2025
Investors
3
See who backed them

The rounds

  1. Aug 2025
    Series D$321M

    Source recordedSEC filing: $313M sold, first sale Jul 2025

Everyone who backed them

Alumni VenturesVC firm1round
Foresite CapitalPrivate equity1round
AmploVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Kriya Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

T1D FundCorporate VCPer its own site
NaryaVC firmPer its own site

Quick answers about Kriya Therapeutics

Who invested in Kriya Therapeutics?

Kriya Therapeutics's investors include Alumni Ventures, Foresite Capital and Amplo.

How much has Kriya Therapeutics raised?

Kriya Therapeutics has raised $321M across 1 round since 2025.

When did Kriya Therapeutics last raise?

Kriya Therapeutics's most recent round was a Series D of $321M in Aug 2025.

What was Kriya Therapeutics's biggest round?

Its most recent round, $321M in Aug 2025, is also its largest on record.

Who backed Kriya Therapeutics first?

Kriya Therapeutics's first round on record, in Aug 2025, was backed by Alumni Ventures, Foresite Capital and Amplo.

What stage is Kriya Therapeutics at?

Kriya Therapeutics's latest named round is a Series D, in Aug 2025.

Where is Kriya Therapeutics based?

Kriya Therapeutics is based in the United States.

Companies like Kriya Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.